Description

BPC-157 + Spray Kit 10MG

We provide BPC-157 + Spray Kit as a 10MG spray-format research product with a stated 99.1% purity and 100 MCG per spray. Furthermore, BPC-157 is a synthetic 15-amino-acid pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV). Consequently, researchers have investigated this peptide across angiogenesis, tissue biology, gastrointestinal research, vascular signaling, and nitric oxide pathways.

Key Attributes

• Brand: AvigenLab
• Product Name: BPC-157 + Spray Kit
• Labeled Compound: BPC-157
• Quantity: 10MG
• Amount Per Spray: 100 MCG
• Stated Purity: 99.1%
• Molecular Type: Synthetic Pentadecapeptide
• Sequence: GEPPPGKPADDAGLV
• Sequence Length: 15 Amino Acids
• Approximate Molecular Weight: 1,419 Da
• Product Format: Spray Bottle
• Classification: Research Use Only
• Human Use: Not For Human Use

BPC-157 + Spray Kit Product Overview

We provide BPC-157 + Spray Kit for research involving peptide signaling, vascular biology, tissue-response mechanisms, gastrointestinal biology, and musculoskeletal research. Moreover, scientific literature describes BPC-157 as a stable gastric pentadecapeptide originally associated with gastric protein fractions and subsequently produced as a defined synthetic sequence.

Additionally, researchers have investigated the compound’s relationship with vascular endothelial growth factor receptor 2 (VEGFR2), endothelial signaling, FAK-paxillin pathways, Egr-1, and nitric oxide systems. Therefore, the compound provides a broad experimental model for examining interconnected cellular pathways involved in vascular and tissue responses.

You can explore additional research materials through our Online Store.

BPC-157 + Spray Kit Product Identification

We identify BPC-157 + Spray Kit as a 10MG spray presentation containing BPC-157 with a stated 99.1% purity. Furthermore, BPC-157 has a clearly defined 15-residue sequence and an approximate molecular weight of 1,419 Da, allowing researchers to distinguish it from other peptide materials through its molecular identity.

Accordingly, the peptide sequence, quantity, purity designation, spray configuration, and research classification provide straightforward reference points for laboratory documentation and inventory management.

Product Category

We classify the material within our research peptide collection for gastrointestinal, vascular, tissue, and musculoskeletal investigations. Accordingly, its research profile extends across several biological systems rather than focusing on a single cellular pathway.

Moreover, studies have examined BPC-157 in models involving gastrointestinal tissue, tendon, ligament, muscle, vascular structures, and other tissues. Consequently, researchers continue to investigate how one defined pentadecapeptide can interact with multiple signaling systems.

Scientific Characteristics

BPC-157 is a synthetic pentadecapeptide containing 15 amino acids arranged in the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. In particular, the sequence contains a proline-rich region that researchers have associated with its structural stability under gastric conditions.

Furthermore, current research identifies several molecular pathways associated with the compound, including VEGFR2, FAK-paxillin, Egr-1, and nitric oxide signaling. Meanwhile, research continues to investigate whether these pathways act independently or as interconnected components of a broader cellular response.

Research Applications

We position BPC-157 + Spray Kit for research involving angiogenesis signaling, vascular biology, nitric oxide pathways, gastrointestinal biology, fibroblast activity, extracellular matrix responses, and musculoskeletal tissue research.

Additionally, experimental studies have reported associations between BPC-157 and VEGF/VEGFR signaling, endothelial responses, fibroblast activity, collagen-related processes, and vascular remodeling. As a result, researchers have investigated the peptide extensively in models involving tissue repair and vascular responses.

Likewise, researchers have examined interactions with the nitric oxide system. However, the available evidence remains predominantly preclinical, and experimental outcomes can vary according to model, preparation, route, concentration, and measured endpoint. Therefore, individual findings require appropriate scientific context.

Product Configuration

We provide BPC-157 + Spray Kit in a 10MG spray-bottle configuration with 100 MCG per spray and a stated 99.1% purity. Accordingly, the total quantity, per-spray specification, purity designation, and physical format establish clear reference points for laboratory inventory and product identification.

Moreover, the spray presentation distinguishes this configuration from conventional vial-based peptide presentations. Consequently, researchers can identify the material according to its product name, molecular identity, quantity, purity, and dedicated spray format.

Product Features

The primary features include a 10MG quantity, 100 MCG per spray, 99.1% stated purity, and synthetic pentadecapeptide composition. Additionally, our packaging clearly communicates the Research Use Only classification.

Furthermore, the scientific profile encompasses vascular signaling, nitric oxide biology, tissue-response mechanisms, and gastrointestinal research. Researchers have also examined FAK-paxillin and Egr-1-related pathways, while other studies have explored interactions involving VEGFR2 and endothelial signaling.

Product Specifications

The sequence and approximate molecular weight correspond with established chemical descriptions of BPC-157 in the scientific literature.

Intended Research Context

We identify BPC-157 + Spray Kit as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine BPC-157 within experimental systems involving vascular responses, gastrointestinal biology, connective-tissue research, nitric oxide signaling, and cellular repair mechanisms. Moreover, recent reviews continue to characterize the evidence base as predominantly preclinical, with important questions remaining around pharmacokinetics, formulation, dosing, and clinical translation.

Nevertheless, experimental findings should not automatically translate into established human outcomes. Therefore, we maintain a clear distinction between documented research observations and clinical or therapeutic claims.

Packaging Information

We present the product in a clearly labeled 10MG spray bottle featuring our AvigenLab product presentation. The packaging identifies BPC-157, displays the 10MG quantity, specifies 100 MCG PER SPRAY, and communicates the stated 99.1% Purity.

Additionally, the label communicates Research Use Only. Therefore, the packaging provides straightforward product identification while supporting consistent laboratory inventory and catalog organization.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific publications concerning BPC-157 do not constitute regulatory approval for this specific AvigenLab presentation.

Moreover, a recent review notes that BPC-157 remains underdeveloped from a pharmaceutical perspective, with limited human pharmacokinetic characterization and no established validated dosing regimen. Consequently, we focus our documentation on molecular identity, research applications, product specifications, and scientific literature rather than presenting experimental observations as established clinical outcomes.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our BPC-157 + Spray Kit provides a defined spray-format research peptide within our product collection. The product name, 10MG quantity, 100 MCG per spray specification, 99.1% purity designation, peptide sequence, and research classification create clear reference points for laboratory inventory.

Moreover, BPC-157 has an extensive preclinical research history spanning gastrointestinal, vascular, musculoskeletal, and tissue-response investigations. Likewise, continued research into VEGFR2, nitric oxide, Egr-1, FAK-paxillin, and related pathways keeps the peptide relevant to experimental tissue and cellular biology.

Product Reference

Our BPC-157 + Spray Kit 10MG provides a defined synthetic pentadecapeptide presentation with a 99.1% purity designation and 100 MCG per spray configuration. We document the material according to its GEPPPGKPADDAGLV sequence, molecular characteristics, spray format, research classification, and established scientific research profile.

Consequently, the product provides researchers with a clearly characterized material for investigating angiogenesis signaling, nitric oxide pathways, vascular responses, gastrointestinal biology, fibroblast activity, and musculoskeletal tissue mechanisms. Furthermore, ongoing research continues to examine the molecular pathways associated with BPC-157 while researchers work to clarify its pharmacological and translational characteristics.